Home About Us Products Clinical Trials News Investors Contact Patents We place great emphasis on the development and protection of our intellectual property. Our patenting strategy is focused on obtaining broad protection for our technologies, extension of patent life and territorial coverage. As part of this strategy, we have claimed composition of matter and method of treatment or therapeutic uses of our stem cell lines, products and their formulations in clinical or preclinical development. We have a new portfolio of patents on the production, characterisation and use of therapeutic exosomes derived from stem cells. Applications are focused on the United States, Europe, Japan, Australia and Canada, and for more recent filings we have also included emerging economic powerhouses such as China, Brazil and South Korea for key patents. In aggregate, we have written or exclusively licensed over 80 issued patents. Section: About Us About ReNeuron Board of Directors Senior Management Advisory Board Working at ReNeuron Patents Subscribe here for our Press Releases: The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: I agree Click here © ReNeuron Group plc 2021 All rights reserved Website design by Carr Kamasa Design Privacy Notice Disclaimer

Home About Us Products Clinical Trials News Investors Contact Email alerts Section: Investors The financial year in review to March 2021 The financial year in review to March 2020 The financial year in review to March 2019 Email alerts General Meetings Investor Centre Corporate Governance Share Price Information Analyst Research Advisors Webcasts and Presentations Financial Reports Financial Calendar Major Shareholdings RNS Notifications Documents and Circulars Declarations Subscribe here for our Press Releases: The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: I agree Click here © ReNeuron Group plc 2021 All rights reserved Website design by Carr Kamasa Design Privacy Notice Disclaimer